Articoli correlati a Molecular Diagnosis of Cancer: Methods and Protocols:...

Molecular Diagnosis of Cancer: Methods and Protocols: 97 - Brossura

 
9781617373961: Molecular Diagnosis of Cancer: Methods and Protocols: 97

Sinossi

We are currently experiencing a fundamental shift in the way in which we approach the characterization of cancer. Never before has the make up of cancer tissues and individual cells been so exhaustively researched and char- terized. We are now capable of producing molecular “fingerprints” that ch- acterize the expression of all known and unknown genes within tumors and their surrounding tissues. More than 30,000 different genes may be measured in each patient’s tumor in a single experiment. Simultaneously, novel therapies that exploit the molecular roadmap have been developed and are now being offered to patients. These novel agents, such as Glivec, Herceptin, Iressa, and others, specifically target individual genes within tumors and can produce d- matic responses in some patients. These drugs are only the forerunners of a coming tidal wave of novel therapeutics that individually target specific m- ecules within cancer cells—more than 300 such agents are currently in phase I or II clinical trials. This is an exciting time for cancer specialists and patients alike. However, if we have learned anything from the past 50 or more years of research into cancer, it is that Lord Beaverbrook, in founding the British national health service in the 1950s, was frighteningly prescient when he defined the primary goal of health care to be “Diagnosis, Diagnosis, Diag- sis. ” Now, more than ever, it is essential that appropriate diagnostic methods and approaches are applied to the selection of patients for treatment.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

Dalla quarta di copertina

The growing tide of novel therapeutics that target molecules within a specific individual's cancer cells-over 300 such agents are currently in phase I or II clinical trials-makes it essential to employ appropriate diagnostic methods and approaches when selecting patients for treatment. In Molecular Diagnosis of Cancer: Methods and Protocols, a panel of leading international experts in molecular diagnostic medicine present a diverse collection of readily reproducible methods, derived from their own research for cancer detection. Highlights include FISH-based methodologies currently used in the diagnosis of solid tumors, the molecular diagnosis of genetic abnormalities by DNA array technologies-including sequence-specific oligonucleotide arrays and CGH arrays-and methodologies directed at the detection of epigenetic events and at quantitative gene expression. The authors apply these novel diagnostic procedures to a broad range of cases taken from cytology, solid tumor pathology, hematology, and rare cell detection, paying special attention to potential future developments and the practical problems of dealing with quality control and accuracy. The protocols presented follow the successful Methods in Molecular Medicine series format, each one offering step-by-step laboratory instructions, an introduction outlining the principle behind the technique, lists of equipment and reagents, and tips on troubleshooting and avoiding known pitfalls.
Cutting-edge and highly practical, Molecular Diagnosis of Cancer: Methods and Protocols offers pathologists providing molecular diagnostic services and researchers seeking molecularly targeted therapeutic approaches a broad array of today's most powerful methods and techniques.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Altre edizioni note dello stesso titolo

9781588291608: Molecular Diagnosis of Cancer: Methods and Protocols: 97

Edizione in evidenza

ISBN 10:  158829160X ISBN 13:  9781588291608
Casa editrice: Humana Pr Inc, 2004
Rilegato

Risultati della ricerca per Molecular Diagnosis of Cancer: Methods and Protocols:...

Foto dell'editore

Editore: Humana, 2010
ISBN 10: 1617373966 ISBN 13: 9781617373961
Nuovo Brossura

Da: Best Price, Torrance, CA, U.S.A.

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. SUPER FAST SHIPPING. Codice articolo 9781617373961

Contatta il venditore

Compra nuovo

EUR 104,64
Convertire valuta
Spese di spedizione: EUR 7,64
In U.S.A.
Destinazione, tempi e costi

Quantità: 2 disponibili

Aggiungi al carrello

Foto dell'editore

Editore: Humana, 2010
ISBN 10: 1617373966 ISBN 13: 9781617373961
Nuovo Brossura

Da: Lucky's Textbooks, Dallas, TX, U.S.A.

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. Codice articolo ABLIING23Mar2811580148298

Contatta il venditore

Compra nuovo

EUR 111,17
Convertire valuta
Spese di spedizione: EUR 3,40
In U.S.A.
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

John M. S. Bartlett
Editore: Humana Press Nov 2010, 2010
ISBN 10: 1617373966 ISBN 13: 9781617373961
Nuovo Taschenbuch
Print on Demand

Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -We are currently experiencing a fundamental shift in the way in which we approach the characterization of cancer. Never before has the make up of cancer tissues and individual cells been so exhaustively researched and char- terized. We are now capable of producing molecular 'fingerprints' that ch- acterize the expression of all known and unknown genes within tumors and their surrounding tissues. More than 30,000 different genes may be measured in each patient's tumor in a single experiment. Simultaneously, novel therapies that exploit the molecular roadmap have been developed and are now being offered to patients. These novel agents, such as Glivec, Herceptin, Iressa, and others, specifically target individual genes within tumors and can produce d- matic responses in some patients. These drugs are only the forerunners of a coming tidal wave of novel therapeutics that individually target specific m- ecules within cancer cells-more than 300 such agents are currently in phase I or II clinical trials. This is an exciting time for cancer specialists and patients alike. However, if we have learned anything from the past 50 or more years of research into cancer, it is that Lord Beaverbrook, in founding the British national health service in the 1950s, was frighteningly prescient when he defined the primary goal of health care to be 'Diagnosis, Diagnosis, Diag- sis. ' Now, more than ever, it is essential that appropriate diagnostic methods and approaches are applied to the selection of patients for treatment. 408 pp. Englisch. Codice articolo 9781617373961

Contatta il venditore

Compra nuovo

EUR 117,69
Convertire valuta
Spese di spedizione: EUR 23,00
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Quantità: 2 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Roulston, Joseph E.|Bartlett, John M. S.
Editore: Humana Press, 2010
ISBN 10: 1617373966 ISBN 13: 9781617373961
Nuovo Brossura
Print on Demand

Da: moluna, Greven, Germania

Valutazione del venditore 4 su 5 stelle 4 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. We are currently experiencing a fundamental shift in the way in which we approach the characterization of cancer. Never before has the make up of cancer tissues and individual cells been so exhaustively researched and char- terized. We are now capable of pr. Codice articolo 4256813

Contatta il venditore

Compra nuovo

EUR 98,54
Convertire valuta
Spese di spedizione: EUR 48,99
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

John M. S. Bartlett
ISBN 10: 1617373966 ISBN 13: 9781617373961
Nuovo Taschenbuch
Print on Demand

Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -We are currently experiencing a fundamental shift in the way in which we approach the characterization of cancer. Never before has the make up of cancer tissues and individual cells been so exhaustively researched and char- terized. We are now capable of producing molecular ¿fingerprints¿ that ch- acterize the expression of all known and unknown genes within tumors and their surrounding tissues. More than 30,000 different genes may be measured in each patient¿s tumor in a single experiment. Simultaneously, novel therapies that exploit the molecular roadmap have been developed and are now being offered to patients. These novel agents, such as Glivec, Herceptin, Iressa, and others, specifically target individual genes within tumors and can produce d- matic responses in some patients. These drugs are only the forerunners of a coming tidal wave of novel therapeutics that individually target specific m- ecules within cancer cells¿more than 300 such agents are currently in phase I or II clinical trials. This is an exciting time for cancer specialists and patients alike. However, if we have learned anything from the past 50 or more years of research into cancer, it is that Lord Beaverbrook, in founding the British national health service in the 1950s, was frighteningly prescient when he defined the primary goal of health care to be ¿Diagnosis, Diagnosis, Diag- sis. ¿ Now, more than ever, it is essential that appropriate diagnostic methods and approaches are applied to the selection of patients for treatment.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 408 pp. Englisch. Codice articolo 9781617373961

Contatta il venditore

Compra nuovo

EUR 117,69
Convertire valuta
Spese di spedizione: EUR 60,00
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

John M. S. Bartlett
ISBN 10: 1617373966 ISBN 13: 9781617373961
Nuovo Taschenbuch
Print on Demand

Da: AHA-BUCH GmbH, Einbeck, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - We are currently experiencing a fundamental shift in the way in which we approach the characterization of cancer. Never before has the make up of cancer tissues and individual cells been so exhaustively researched and char- terized. We are now capable of producing molecular 'fingerprints' that ch- acterize the expression of all known and unknown genes within tumors and their surrounding tissues. More than 30,000 different genes may be measured in each patient's tumor in a single experiment. Simultaneously, novel therapies that exploit the molecular roadmap have been developed and are now being offered to patients. These novel agents, such as Glivec, Herceptin, Iressa, and others, specifically target individual genes within tumors and can produce d- matic responses in some patients. These drugs are only the forerunners of a coming tidal wave of novel therapeutics that individually target specific m- ecules within cancer cells-more than 300 such agents are currently in phase I or II clinical trials. This is an exciting time for cancer specialists and patients alike. However, if we have learned anything from the past 50 or more years of research into cancer, it is that Lord Beaverbrook, in founding the British national health service in the 1950s, was frighteningly prescient when he defined the primary goal of health care to be 'Diagnosis, Diagnosis, Diag- sis. ' Now, more than ever, it is essential that appropriate diagnostic methods and approaches are applied to the selection of patients for treatment. Codice articolo 9781617373961

Contatta il venditore

Compra nuovo

EUR 122,12
Convertire valuta
Spese di spedizione: EUR 63,45
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello

Foto dell'editore

Roulston, Joseph E. (Editor) / Bartlett, John M. S. (Editor)
Editore: Humana Press, 2010
ISBN 10: 1617373966 ISBN 13: 9781617373961
Nuovo Paperback

Da: Revaluation Books, Exeter, Regno Unito

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Paperback. Condizione: Brand New. 2nd edition. 408 pages. 9.25x6.10x0.92 inches. In Stock. Codice articolo x-1617373966

Contatta il venditore

Compra nuovo

EUR 164,34
Convertire valuta
Spese di spedizione: EUR 28,67
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

Quantità: 2 disponibili

Aggiungi al carrello

Foto dell'editore

Editore: Humana, 2010
ISBN 10: 1617373966 ISBN 13: 9781617373961
Nuovo Brossura

Da: Ria Christie Collections, Uxbridge, Regno Unito

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. In. Codice articolo ria9781617373961_new

Contatta il venditore

Compra nuovo

EUR 179,71
Convertire valuta
Spese di spedizione: EUR 13,74
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello